한빛사논문
Jeongmin Park a, So-Young Rah b, Hyeong Seok An c, Jong Youl Lee c, Gu Seob Roh c, Stefan W. Ryter d, Jeong Woo Park a, Chae Ha Yang e, Young-Joon Surh f,g, Uh-Hyun Kim h, Hun Taeg Chung a, Yeonsoo Joe a
aSchool of Biological Sciences, University of Ulsan, Ulsan 44610, Republic of Korea
bNational Creative Research Laboratory for Ca2+ signaling Network, Chonbuk National University Medical School, Jeonju 54907, Republic of Korea
cDepartment of Anatomy and Convergence Medical Science, Institute of Health Sciences, College of Medicine, Gyeongsang National University, Jinju 52727, Republic of Korea
dProterris Inc., Boston, MA 02118, USA
eCollege of Korean Medicine, Daegu Haany University, Daegu 42158, Republic of Korea
fDepartment of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul 08826, Republic of Korea
gCancer Research Institute, Seoul National University, Seoul 03080, Republic of Korea
hDepartment of Biochemistry, School of Medicine, Wonkwang University, Iksan 54538, Republic of Korea
Corresponding authors: Hun Taeg Chung, Yeonsoo Joe
Abstract
Objective: Emerging evidence suggests that crosstalk between Kupffer cells (KCs) and hepatocytes protects against non-alcoholic fatty liver disease (NAFLD). However, the underlying mechanisms that lead to the reduction of steatosis in NAFLD remain obscure.
Methods: Ttp+/+ and Ttp-/- mice were fed with a high-fat diet. Hepatic steatosis was analyzed by Nile Red staining and measurement of inflammatory cytokines. Lipid accumulation and cell death were evaluated in co-culture systems with primary hepatocytes and KCs derived from either Ttp+/+ or Ttp-/- mice.
Results: Tristetraprolin (TTP), an mRNA binding protein, was essential for the protective effects of metformin in NAFLD. Metformin activated TTP via the AMPK-Sirt1 pathway in hepatocytes and KCs. TTP inhibited TNF-α production in KCs, which in turn decreased hepatocyte necroptosis. Downregulation of Rheb expression by TTP promoted hepatocyte lipophagy via mTORC1 inhibition and increased nuclear translocation of transcription factor-EB (TFEB). Consistently, TTP-deficient NAFLD mice failed to respond to metformin with respect to alleviation of hepatic steatosis, protection of hepatocyte necroptosis, or induction of lipophagy.
Conclusions: TTP, which is essential for the protective effects of metformin, may represent a novel primary therapeutic target in NAFLD.
논문정보
관련 링크
연구자 키워드
연구자 ID
관련분야 연구자보기
소속기관 논문보기
관련분야 논문보기
해당논문 저자보기